Savolitinib: A Promising Targeting Agent for Cancer

SIMPLE SUMMARY: Savolitinib is a highly specific inhibitor of the MET tyrosine kinase. Both preclinical and clinical studies have shown its potential as a treatment for various cancers, including non-small cell lung cancer (NSCLC) as well as breast, head and neck, colorectal, gastric, pancreatic, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Tae Seung, Kim, Jun Yeol, Lee, Myeong Hwan, Cho, In Rae, Paik, Woo Hyun, Ryu, Ji Kon, Kim, Yong-Tae, Lee, Sang Hyub
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571651/
https://www.ncbi.nlm.nih.gov/pubmed/37835402
http://dx.doi.org/10.3390/cancers15194708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571651/
https://www.ncbi.nlm.nih.gov/pubmed/37835402
http://dx.doi.org/10.3390/cancers15194708

Ejemplares similares